S-18326 is an orally active direct thrombin inhibitor that functions by reversibly binding to the active site of thrombin, thereby preventing the conversion of fibrinogen to fibrin and inhibiting thrombus formation. This compound effectively prolongs clotting times in human plasma and has shown antithrombotic efficacy in various animal models while maintaining normal platelet levels. S-18326 is suitable for research applications related to thromboembolic diseases.
S-18326 is an orally active direct thrombin inhibitor that functions by reversibly binding to the active site of thrombin, thereby preventing the conversion of fibrinogen to fibrin and inhibiting thrombus formation. This compound effectively prolongs clotting times in human plasma and has shown antithrombotic efficacy in various animal models while maintaining normal platelet levels. S-18326 is suitable for research applications related to thromboembolic diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: